Angioimmunoblastic lymphadenopathy following typhoid AB vaccination and terminating in disseminated infection.
Angioimmunoblastic lymphadenopathy (AIL) followed typhoid AB vaccination in a patient whose subsequent clinical course was rapidly progressive. At autopsy, extensive lymphadenopathy with features characteristic of AIL and disseminated infection with Escherichia coli, Candida, and Aspergillus were seen. Vaccination is a presumptive precipitating factor in AIL.
D000328:Adult; D001228:Aspergillosis / Q000209:etiology; D002177:Candidiasis / Q000209:etiology; D004927:Escherichia coli Infections / Q000209:etiology; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology; D007108:Immune Tolerance; D007119:Immunoblastic Lymphadenopathy / Q000209:etiology* / Q000473:pathology; D008297:Male; D018805:Sepsis / Q000209:etiology; D014436:Typhoid-Paratyphoid Vaccines / Q000009:adverse effects* / Q000276:immunology; D014611:Vaccination / Q000009:adverse effects*
D014436:Typhoid-Paratyphoid Vaccines